Annual D&A
$15.93 M
+$2.74 M+20.75%
31 December 2023
Summary:
Pharming Group NV annual depreciation & amortization is currently $15.93 million, with the most recent change of +$2.74 million (+20.75%) on 31 December 2023. During the last 3 years, it has risen by +$7.61 million (+91.54%). PHAR annual D&A is now -18.79% below its all-time high of $19.61 million, reached on 31 December 2021.PHAR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.74 M
+$3.04 M+1036.18%
30 September 2024
Summary:
Pharming Group NV quarterly depreciation & amortization is currently $2.74 million, with the most recent change of +$3.04 million (+1036.18%) on 30 September 2024. Over the past year, it has dropped by -$159.00 thousand (-5.48%). PHAR quarterly D&A is now -78.47% below its all-time high of $12.74 million, reached on 31 December 2021.PHAR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$15.93 M
-$159.00 K-0.99%
30 September 2024
Summary:
Pharming Group NV TTM depreciation & amortization is currently $15.93 million, with the most recent change of -$159.00 thousand (-0.99%) on 30 September 2024. Over the past year, it has increased by +$584.00 thousand (+3.81%). PHAR TTM D&A is now -19.31% below its all-time high of $19.74 million, reached on 31 March 2022.PHAR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.8% | -5.5% | +3.8% |
| 3 y3 years | +91.5% | +16.8% | +73.1% |
| 5 y5 years | +112.3% | +5.5% | +60.8% |
PHAR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -18.8% | +91.5% | -78.5% | +1036.2% | -19.3% | +73.1% |
| 5 y | 5 years | -18.8% | +174.5% | -78.5% | +1036.2% | -19.3% | +174.5% |
| alltime | all time | -18.8% | +2567.9% | -78.5% | +1036.2% | -19.3% | >+9999.0% |
Pharming Group NV Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.74 M(-1036.2%) | $15.93 M(-1.0%) |
| June 2024 | - | -$293.00 K(-104.9%) | $16.09 M(-17.7%) |
| Mar 2024 | - | $5.92 M(-21.6%) | $19.54 M(+22.7%) |
| Dec 2023 | $15.93 M(+20.8%) | $7.55 M(+160.3%) | $15.93 M(+3.8%) |
| Sept 2023 | - | $2.90 M(-8.2%) | $15.34 M(+6.6%) |
| June 2023 | - | $3.16 M(+37.1%) | $14.39 M(+8.2%) |
| Mar 2023 | - | $2.31 M(-66.9%) | $13.30 M(+0.9%) |
| Dec 2022 | $13.19 M(-32.7%) | $6.97 M(+257.0%) | $13.19 M(-30.4%) |
| Sept 2022 | - | $1.95 M(-5.8%) | $18.96 M(-2.0%) |
| June 2022 | - | $2.07 M(-5.3%) | $19.36 M(-1.9%) |
| Mar 2022 | - | $2.19 M(-82.8%) | $19.74 M(+0.6%) |
| Dec 2021 | $19.61 M(+135.9%) | $12.74 M(+442.5%) | $19.61 M(+113.1%) |
| Sept 2021 | - | $2.35 M(-4.3%) | $9.20 M(-1.3%) |
| June 2021 | - | $2.46 M(+19.0%) | $9.32 M(+9.7%) |
| Mar 2021 | - | $2.06 M(-11.7%) | $8.50 M(+2.2%) |
| Dec 2020 | $8.31 M(+43.3%) | $2.34 M(-5.3%) | $8.31 M(+38.5%) |
| Sept 2020 | - | $2.47 M(+51.2%) | $6.00 M(-2.2%) |
| June 2020 | - | $1.63 M(-13.2%) | $6.14 M(-0.4%) |
| Mar 2020 | - | $1.88 M(+8071.3%) | $6.16 M(+6.2%) |
| Dec 2019 | $5.80 M | $23.00 K(-99.1%) | $5.80 M(-41.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2019 | - | $2.60 M(+57.0%) | $9.90 M(+16.8%) |
| June 2019 | - | $1.66 M(+9.1%) | $8.48 M(+7.9%) |
| Mar 2019 | - | $1.52 M(-63.2%) | $7.86 M(+4.7%) |
| Dec 2018 | $7.50 M(+83.1%) | $4.12 M(+250.3%) | $7.50 M(+67.1%) |
| Sept 2018 | - | $1.18 M(+13.6%) | $4.49 M(+2.8%) |
| June 2018 | - | $1.04 M(-11.0%) | $4.37 M(+0.0%) |
| Mar 2018 | - | $1.16 M(+4.8%) | $4.36 M(+6.5%) |
| Dec 2017 | $4.10 M(+415.3%) | $1.11 M(+5.4%) | $4.10 M(+24.9%) |
| Sept 2017 | - | $1.05 M(+1.8%) | $3.28 M(+38.0%) |
| June 2017 | - | $1.04 M(+15.5%) | $2.38 M(+56.2%) |
| Mar 2017 | - | $896.60 K(+205.4%) | $1.52 M(+91.2%) |
| Dec 2016 | $795.10 K(+33.2%) | $293.60 K(+95.7%) | $795.10 K(+22.0%) |
| Sept 2016 | - | $150.00 K(-16.9%) | $651.70 K(-1.3%) |
| June 2016 | - | $180.40 K(+5.4%) | $660.20 K(+4.3%) |
| Mar 2016 | - | $171.10 K(+13.9%) | $632.70 K(+6.0%) |
| Dec 2015 | $596.90 K(-51.6%) | $150.20 K(-5.2%) | $597.00 K(+33.6%) |
| Sept 2015 | - | $158.50 K(+3.7%) | $446.80 K(+55.0%) |
| June 2015 | - | $152.90 K(+12.9%) | $288.30 K(+112.9%) |
| Mar 2015 | - | $135.40 K | $135.40 K |
| Dec 2005 | $1.23 M | - | - |
FAQ
- What is Pharming Group NV annual depreciation & amortization?
- What is the all time high annual D&A for Pharming Group NV?
- What is Pharming Group NV annual D&A year-on-year change?
- What is Pharming Group NV quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Pharming Group NV?
- What is Pharming Group NV quarterly D&A year-on-year change?
- What is Pharming Group NV TTM depreciation & amortization?
- What is the all time high TTM D&A for Pharming Group NV?
- What is Pharming Group NV TTM D&A year-on-year change?
What is Pharming Group NV annual depreciation & amortization?
The current annual D&A of PHAR is $15.93 M
What is the all time high annual D&A for Pharming Group NV?
Pharming Group NV all-time high annual depreciation & amortization is $19.61 M
What is Pharming Group NV annual D&A year-on-year change?
Over the past year, PHAR annual depreciation & amortization has changed by +$2.74 M (+20.75%)
What is Pharming Group NV quarterly depreciation & amortization?
The current quarterly D&A of PHAR is $2.74 M
What is the all time high quarterly D&A for Pharming Group NV?
Pharming Group NV all-time high quarterly depreciation & amortization is $12.74 M
What is Pharming Group NV quarterly D&A year-on-year change?
Over the past year, PHAR quarterly depreciation & amortization has changed by -$159.00 K (-5.48%)
What is Pharming Group NV TTM depreciation & amortization?
The current TTM D&A of PHAR is $15.93 M
What is the all time high TTM D&A for Pharming Group NV?
Pharming Group NV all-time high TTM depreciation & amortization is $19.74 M
What is Pharming Group NV TTM D&A year-on-year change?
Over the past year, PHAR TTM depreciation & amortization has changed by +$584.00 K (+3.81%)